TG Therapeutics, Inc. (TGTX)
55.98
-0.73
(-1.29%)
USD |
NASDAQ |
Sep 04, 16:00
56.00
+0.02
(+0.04%)
After-Hours: 20:00
TG Therapeutics Cash and Short Term Investments (Annual) : 141.97M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 141.97M |
| December 31, 2024 | 311.00M |
| December 31, 2023 | 217.51M |
| December 31, 2022 | 161.68M |
| December 31, 2021 | 314.76M |
| December 31, 2020 | 605.43M |
| December 31, 2019 | 140.44M |
| December 31, 2018 | 68.81M |
| December 31, 2017 | 84.72M |
| December 31, 2016 | 44.89M |
| December 31, 2015 | 77.23M |
| December 31, 2014 | 78.78M |
| December 31, 2013 | 40.49M |
| December 31, 2012 | 16.46M |
| Date | Value |
|---|---|
| December 31, 2011 | 9.748M |
| December 31, 2010 | 0.4787M |
| December 31, 2009 | 0.018M |
| December 31, 2008 | 0.8365M |
| December 31, 2007 | 0.6497M |
| December 31, 2006 | 3.029M |
| December 31, 2005 | 10.83M |
| December 31, 2004 | 5.420M |
| December 31, 2003 | 7.766M |
| December 31, 2002 | 0.1163M |
| December 31, 2001 | 1.592M |
| December 31, 2000 | 2.663M |
| December 31, 1999 | 3.473M |
| December 31, 1998 | 5.836M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Krystal Biotech, Inc. | 827.79M |
| MAIA Biotechnology, Inc. | 8.658M |
| Alnylam Pharmaceuticals, Inc. | 2.908B |
| BioMarin Pharmaceutical, Inc. | 1.561B |
| Cytokinetics, Inc. | 885.34M |